Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAP1A | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | RP11-295K3.1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | ZBED2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | SRRT | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | SLFN12L | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | CBLL1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | CHMP2A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | TBX3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | MYO1A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
mRNA | PLD4 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |